Objective-Comparative studies are lacking that show the effects of different microenvironments on the activity of engrafted stem cells after myocardial infarction (MI). Here, we analyzed the temporal and spatial variations of angiogenesis, collateralization, and the expression of Akt-related signals after MI to test whether the effects of endothelial progenitor cells (EPCs) were different. Methods and Results-After the induction of MI, pigs were selected that did not develop a collateral coronary circulation (R0) or developed a significant collateral coronary circulation (R2). Both sets were allocated randomly to 4 groups: phosphate-buffered saline (intramyocardial injection of phosphate-buffered saline), EPC transplantation, LY294002 (intramyocardial injection of an Akt inhibitor), and EPCs plus LY294002. Infarcted porcine hearts at different time points and under different collateralized conditions exhibited a variety of vascular microenvironments. At 14 days post-MI, angiogenesis and the expression of Akt-mediated angiogenic cytokines predominated in R2 porcine hearts. When grafted into this microenvironment, EPCs induced the greatest effects in impeding the development of heart failure, preserving left ventricular function and dimensions, and inhibiting infarct expansion. LY294002 significantly reduced these effects. Conclusion-These findings suggest that the microenvironment that coexists with collateralization and Akt-mediated angiogenesis appears to be more beneficial to cardiac repair induced by EPC therapy than other niches after MI. (Arterioscler Thromb Vasc Biol. 2012;32:910-923.) contributed equally to this work. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/An expanded Materials and Methods section containing details regarding animal allocation, animal model, study design, biopsy, blood high-sensitivity C-reactive protein measurement, myeloperoxidase detection, manipulation of EPCs, coronary angiography, echocardiography, histology, immunofluorescence, quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR), immunoblotting, and statistics is available in the onlineonly Data Supplement.
E ndothelial progenitor cells (EPCs) have shown regenerative potential in myocardial ischemic animal models with respect to cardiomyocytes and new blood vessel formation. 1 With the recent surge of interest in EPC-based cardiac regenerative therapies for patients with myocardial infarction (MI), 2,3 the identification of clinically applicable strategies is of paramount importance. Nevertheless, the implementation of this novel approach in a clinical setting requires the understanding of a number of key aspects that remain poorly understood. Among the main issues, the optimal timing for therapy and the most appropriate stem cell microenvironment are particularly important to maximize cell transplantation efficiency. For example, in the REPAIR-AMI trial, patients treated for up to 4 days after MI showed no benefit, whereas later treatment (days 4 -8) provided an enhanced improve-ment of ejection fraction during follow-up. 3 The initial pilot study by Erbs et al demonstrated that EPC transplantation (Tx) improves left ventricular ejection fraction (LVEF) and remodeling to a greater degree in patients with acute MI than in patients with old MI. 2 Although it is not entirely clear which variables might influence outcome, where ischemic/ necrotic tissue may provide an entirely different environment (or "niche") to dictate cell fate, it is evident from various studies that transplanted stem cell function and numbers are limited by inflammation, insufficient vascular supply that results from ischemia, and loss of angiogenic factors after MI. 4, 5 Sustained coronary occlusion may lead to the progressive extension of infarcted areas and to fibrous development, and the regenerative response induced by cell therapy is limited in its ability to salvage a deteriorating myocardium. 6 However, when stem cells were modified with powerful angiogenic factors, including vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1), or basic fibroblast growth factor (bFGF), and then transplanted into the ischemic rat heart, a better prognosis was achieved because of improved angiogenesis and restored global cardiac function. [7] [8] [9] These results indicate that the expression of angiogenic factors is a key method of enhancing stem cell therapy. One problem that remains is whether the persistent expression of foreign proteins could lead to malignant transformation or late cell failure. The strategies for exogenous gene or protein treatments are limited. Exploration of the host endogenous cytoprotection or angiogenesis mechanisms to improve the effect of stem cell therapy would be more favorable.
Phosphatidylinositol 3-kinase (PI3K)/Akt signaling has been reported to play a major role in cell survival, cell proliferation, and angiogenesis in response to hypoxia. Akt signaling via parallel targeting with VEGF, bFGF, or Ang-1 plays an indispensable role in the induction of angiogenesis. [10] [11] [12] However, whether the change in the expression level of Akt signaling-related proteins after MI is implicated in the neovascularization induced by stem cell therapy remains unknown.
To investigate these questions, we used a porcine model of MI and selected animals that either had no collateral coronary circulation (CCC) (R0) or had an abundant CCC (ՆR2) at different postinfarct time points after MI. The present study was designed to gain insights into the temporal progression and spatial variations in the expression changes of inflammatory factors, angiogenic cytokines, collateral circulation, and angiogenesis in different ischemic microenvironments. We then compared the effects of these microenvironments on myocardial repair induced by autologous EPC therapy and determined whether Akt signals are involved in the underlying mechanisms.
Histology and Immunofluorescence
The size of the infarct was obtained by calculating the percentage of the infarcted area against the whole LVEF area with the use of a digital image program (Scion ImageJ). The biopsy tissues and the peri-infarct regions from the autopsy specimens were embedded in paraffin or frozen for cryostat sectioning and were then stained by hematoxylin and eosin or immunofluorescence assays.
qRT-PCR and Immunoblotting
Peri-infarct myocardial tissues from the biopsied or autopsied tissues were harvested and pulverized to extract RNA or protein for qRT-PCR and immunoblotting. Figure I 
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Results
A flow chart of the study protocol is shown in Figure I in the online-only Data Supplement. Of the 113 experimental pigs used in these studies, 5 normal animals were randomly chosen to be euthanized for the measurement of baseline levels of Akt-mediated cytokines and growth factors in cardiac tissue. Overall, 108 pigs underwent surgery. A total of 60 pigs with LVEF Ͻ45% and with collateral vessels of R0 or R2 evaluated by the Rentrop score underwent myocardial biopsy. After biopsy, 5 R0 or R2 pigs at 1, 14, and 28 days post-MI received a local intramyocardial injection of EPCs. Meanwhile, we performed the same surgery to induce an MI model in a further 105 pigs. Ten pigs with R0 at 1, 14, and 28 days post-MI were randomly divided into receiving either a local intramyocardial injection of phosphate-buffered saline (PBS) or LY294002; an additional 10 pigs with R2 were randomly assigned to receive either an injection of PBS or LY294002 with EPCs. To investigate the effects of LY294002 on the Akt-mediated pathway in the repair of ischemic myocardium, we chose 10 pigs with R0 or R2 at 14 days post-MI. EPCs and LY294002 were coinjected in R0 pigs, and LY294002 alone was injected into the R2 pigs. Thereafter, all animals were followed up for 1 month. No deaths occurred in this cohort of pigs during cell transplantation. Thirteen pigs died during follow-up. A total of 87 pigs survived to undergo serial functional studies by the end of this part of the study ( Figure I in the online-only Data Supplement). No marked difference in mortality was found between any of the groups.
Serial Changes of Inflammation and Angiogenesis in the Infarcted Pigs
We initially examined the temporal changes in the inflammatory reaction and blood vessel density in the host heart with the use of a porcine model of MI. Hematoxylin and eosin staining showed that the strongest inflammatory reactions were observed at 1 day post-MI ( Figure 1A) , especially in the R0 pigs. This observation was confirmed by the occurrence of the highest myeloperoxidase level and high-sensitivity C-reactive protein at this time point, which was a quantitative index for the inflammatory reaction ( Figure 1B and 1C ). After 14 days, no significant inflammation was observed in any of the infarcted hearts. Blood vessel density was assessed by anti-factor VIII staining. Capillaries were identified as a single layer of factor VIII-positive cells with a flattened morphology, whereas arterioles were recognized as that of the factor VIII ϩ vessels with a luminal diameter of 10 to 100 m ( Figure 1D ) and as staining positive for ␣-smooth muscle actin with a visible lumen ( Figure 1E , arrows). A significant increase in the mean arteriolar and capillary densities was observed in the R2 animals and peaked on day 14 post-MI ( Figure 1F and 1G).
Temporal Expression of Inflammatory and Akt-Mediated Factors After MI
Real-time reverse transcription-PCR was performed to quantify the mRNA expression of cardiac inflammatory and Akt-mediated factors in the peri-infarct border biopsy tissues. Compared with the baseline levels (day 0), the highest expression levels of interleukin-1 (IL-1), monocyte chemotactic protein-1 (MCP-1), and tumor necrosis factor ␣ (TNF␣) occurred within 1 day post-MI in both models; these gradually declined thereafter and were similar in both groups after 7 days post-MI ( Figure 2A ). In the R2 model, the gene expression of IL-1, MCP-1, and TNF␣ within 3 days was lower than in the R0 model (PϽ0.05). However, the angiogenic cytokines (Ang-1, bFGF, and VEGF) showed opposite changes: bFGF, VEGF, and Ang-1 were increased by 7-fold, 6-fold, and 11-fold, respectively, at 1 day post-MI and peaked at 14 days post-MI with 11-fold, 7-fold, and 14-fold differences, respectively, in the R2 group compared with the baseline level; the increase of these expression levels was much less in the R0 group compared with the R2 group ( Figure 2A ). There was an 8-fold difference in the expression of Akt at 14 days post-MI in the R2 model compared with the baseline levels, but this increase was relatively low in the R0 model with peaks that were different by 5-fold ( Figure 2A ). At day 28 post-MI, these angiogenic factors showed no significant differences between the R0 and R2 groups. To verify the correlation between the mRNA and protein levels, we measured the protein expression of 1 representative factor, Akt, by Western blotting. Immunoblots showed that the level of Akt was consistently higher in the R2 group compared with the R0 group over 14 days, and the protein levels correlated well with mRNA levels ( Figure 2B ). Similar to Akt expression, both representative Western blots with anti-Ser473 and anti-Thr408 antibodies and the bar graph of both Ser473 and Thr408 levels showed the greatest protein and phosphorylation levels in the pigs with R2 14 days after MI ( Figure 2B ).
To determine the relationship between proangiogenic mediators and vascular endothelial cells (ECs), we performed double staining with proangiogenic cytokines and the EC marker factor VIII. Immunofluorescence showed that MCP-1 and TNF␣ were rarely expressed by the vascular ECs, and the ECs in some blood vessels expressed IL-1. bFGF, Ang-1, VEGF, and Akt was more abundantly expressed in the R2 group than in the R0 group. bFGF, Ang-1, and VEGF were expressed mainly in the cytoplasm of the vascular ECs. Akt was expressed mainly in the cytoplasm of ECs and in cardiomyocytes in regions with a rich vasculature ( Figure 2C , arrows). These expression patterns were seen with the greatest significance in the R2 day 14 animals. Therefore, we concluded that vascular ECs in the ischemic myocardial niche played a main role in intrinsic angiogenesis by secreting proangiogenic cytokines. These data indicate that the inflammatory reaction was maximal on day 1, especially in the infarcted hearts with R0; however, collateralization, angiogenesis, and Akt-mediated angiogenic cytokines were at their highest levels at 14 days and reached the greatest extent in the infarcted hearts with R2. In addition, the expression levels of Akt in the R2 group at 14 days post-MI correlated positively with the mRNA expression of VEGF, bFGF, and Ang-1, and the vessel density (rϭ0.953, 0.898, 0.925, and 0.949, respectively; PϽ0.05 for all comparisons).
Therefore, we chose 1, 14, and 28 days post-MI as the time points of cell therapy to investigate the effect of various niches in infarcted swine model on myocardial repair induced by EPC therapy, or with the injection of PBS, LY294002 (an Akt inhibitor), or EPCs plus LY294002.
EPC Characterization
After 21 to 28 days of culture, late outgrowth EPCs were used as the donor cells. Before transplantation, a small portion of the cells were chosen at random to identify EPC characteristics. Two aspects have predominantly used to identify EPCs: (1) cell surface markers that indicate both cellular naïveté and endothelial origin; and (2) functional phenotypes that imply the presence of endothelial precursors. 14 The late outgrowth EPCs formed in vitro colonies with a typical cobblestone morphology, with an angiogenic capability and strong expression of the blood EC marker factor VIII, but they did not express the cardiomyocytic marker myosin heavy chain ( Figure 3A ). In line with the literature reported by Le Ricousse-Roussanne et al, 15 Fadini et al, 16 and Zhang et al, 17 these EPCs expressed the cellular naïveté marker, CD133 (82.95Ϯ1.05%) and the hematopoietic progenitor cell marker CD117 (86.20Ϯ1.38%); had EC-like characteristics, such as the expression of CD34 (88.43Ϯ1.28%), CD31 (84.64Ϯ1.64%), and KDR (79.84Ϯ1.34%); and were negative for the panleukocyte marker CD45 ( Figure 3B ). The late outgrowth EPCs had significantly higher secretion levels of angiogenic cytokines, including VEGF, bFGF, and Ang-1, than those of inflammatory factors, including IL-1, MCP-1, and TNF␣ ( Figure 3C ). Representative images from hematoxylin and eosin staining and immunofluorescent staining with factor VIII to measure blood vessel density from serial cardiac biopsy samples (day 1 [D1], D14, and D28) obtained from the animal hearts with R0 and R2, respectively. Images show the strongest inflammatory response at D1 post-myocardial infarction (MI) in the infarcted hearts with R0 (A). However, both the capillary density and the arteriolar density (D, white arrows) were seen to be the greatest in the peri-infarct area of pigs with R2 at D14 post-MI. E, Capillaries were identified as a single layer of factor VIII-positive cells (red), whereas arterioles were recognized as staining positive for ␣-smooth muscle actin (green) and as having a visible lumen (arrows). Images presented in E show the same trend as those in D: a significant increase in the mean arteriolar and capillary densities was observed in the R2 animals and peaked on D14 post-MI. Scale barsϭ50 m. B, C, F, and G, Quantitative analysis of myeloperoxidase (MPO), high-sensitivity C-reactive protein (hs-CRP), arteriolar density, and capillary density at days 1, 3, 7, 14, 21, and 28 post-MI in the infarcted porcine hearts with R0 or R2. PϽ0.05: *vs the baseline (D0), †vs R0 at each time point, ‡vs D1, §vs D3, vs D7, and ¶vs D14 post-MI in each group (nϭ5 in each group).
Figure 2.
Serial expression changes of multiple cytokines in peri-infarct myocardium after endothelial progenitor cell (EPC) transplantation. A, Quantitative real-time reverse transcription-polymerase chain reaction was performed to measure the level of gene expression from the samples harvested from the peri-infarct myocardium of pigs at the baseline (pre-myocardial infarction [MI], day 0 [D0]) and 1, 3, 7, 14, 21, and 28 days after MI. Compared with the baseline, the infarcted hearts with R0 expressed the highest levels of the inflammatory cytokines at D1 post-MI, and the greatest degree of Akt-mediated angiogenic cytokines was seen in the hearts with R2 at D14 post-MI. B, Representative immunoblot electrophoresis and the subsequent quantification showed the protein levels of Akt, phospho-Akt (pAkt) Ser473, and pAkt Thr308, respectively. The ratio of phosphorylated Akt at Thr308 and Ser473/total Akt was calculated (nϭ5 per group). PϽ0.05: *vs the baseline (D0, before myocardial infarction); †vs R0 at each time point,
Host Collateralization Augments the Effects of EPC Therapy on Cardiac Function and Cardiac Geometry
At 30 days after Tx, the LVEFs of PBS-treated porcine hearts in both the R0 and R2 groups showed no significant change in comparison with their preinjection function. EPC treatment at 1 or 14 days post-MI in both models resulted in an improvement of LVEF and LV-fractional shortening compared with the LVEF and LV-fractional shortening of animals that received a PBS injection alone; the maximal improvement was observed in the R2 pigs treated by EPC at 14 days post-MI ( Figure 4A ). In contrast, in comparison with the respective baseline levels, the injection of PBS sustained the dilation of both the LV end systolic volume and the LV end diastolic volume. The injection of LY294002 alone exacerbated this remodeling process. However, Tx significantly ameliorated these indices, and the effect was found to be the greatest in the R2 pigs that received cell therapy at 14 days post-MI. Interestingly, the improvement in these indices that had resulted from Tx was abrogated by coinjection of LY294002. No marked difference in these indices was found in either group that received cell therapy at 28 days post-MI. Echocardiography showed that the systolic activity of the left ventricular (LV) wall at 30 days after treatment was stronger in the R2 group with Tx at 14 days post-MI than in the other groups ( Figure 4B , arrows). Consistent with the changes in LV cardiac function, compared with the values before cell therapy, porcine left ventricles showed progressive thinning of end diastolic interventricular septum thickness after MI, as well as thickening of the end diastolic posterior wall thickness and dilation of the LV-end-diastolic diameter. Injection of PBS alone aggravated these LV remodeling changes, and LY294002 treatment further worsened them ( Table II in the online-only Data Supplement). For the EPC-treated groups, at 1 month after cell therapy, all LV remodeling indices were significantly better than those in the PBS groups (PϽ0.05). The greatest improvement was observed in the R2 pigs that had received cell therapy at 14 days post-MI (PϽ0.05), and LY294002 treatment abrogated this effect (PϽ0.05).
Akt Signaling in the Host Vascular Niche Promotes Neovascularization Induced by EPC Therapy
Before EPC therapy, coronary angiography demonstrated total occlusion of the left anterior descending artery ( Figure 5 A, black arrows), and the distal region from the ligation site was perfused via collateral vessels in the pigs with R2 but not in those with R0 CCC ( Figure 5A , white arrowheads). At 1 month after cell therapy, although EPC therapy showed no significant increment of the Rentrop grades between the R0ϩTx and R2ϩTx groups compared with those before cell therapy ( Figure 5C ), visible collateral vessels (Ն100 m in diameter 18 ) that branched from the distal portion of the left anterior descending artery in the direction of the infarct were marked in the EPC-treated animals, and the numbers of these collateral vessels were significantly increased in the R2ϩTx pigs that received cell therapy at 14 days post-MI compared with the respective R0ϩTx or PBS groups (4.0Ϯ0.7 versus 2.2Ϯ0.4 or 1.0Ϯ0.3, all PϽ0.05; Figure 5A and 5D). Tissue sections were stained for anti-factor VIII antibody (to detect ECs). The numbers of arterioles and capillaries were greater in the R2 pigs that received cell therapy at 1 or 14 days post-MI than in the PBS groups (PϽ0.05) and were the greatest in the EPC-treated R2 pigs at 14 days post-MI in comparison with the R0ϩTx and PBS groups (Figure 5B, 5E, and 5F ). Double-staining with smooth muscle actin and endothelial factor VIII showed the same increase of the numbers of arterioles in the EPC-treated R2 pigs at 14 days post-MI (data not shown). Treatment with LY294002 appeared to prevent significant increases in vessel density.
The Host Vascular Niche Enhances the Effects of Infarct Size Reduction of EPC Therapy
As shown in the Table, compared with PBS treatment alone, EPC therapy resulted in a significant reduction in infarct size of the pigs that received EPC therapy at 1 or 14 days post-MI, and the effect was the greatest in the R2 group that received cell therapy at 14 days post-MI (18.5%; PϽ0.05). LY294002 abolished this effect of EPC therapy. The infarct size showed no significant differences between both the R0 and R2 models that received cell therapy at 28 days post-MI. There was no significant difference in arterial blood pressure, arterial P O 2 , and heart rate between all groups 1 month after cell therapy. Triphenyl tetrazolium chloride staining showed that the infarct size 1 month after EPC therapy was given at 14 days post-MI was significantly smaller in the R2ϩTx group than those in other groups, and some myocardial regeneration had occurred ( Figure II 
Sustained Upregulation of Akt Signaling Factors Is Attributed to Host Vascular Niche
To determine the levels of expression of Akt-mediated proangiogenic cytokines in the ischemic myocardium after Tx, we measured mRNA levels of multiple angiogenic cytokines in the myocardium using qRT-PCR. At day 1 and day 14, MI (PBS injection) induced an overall increase in cytokine expression, and Tx significantly augmented this response. At day 28, although the expression levels of Akt, VEGF, bFGF and Ang-1 fell below baseline levels in the PBS group, they increased to supraphysiological levels in the EPC group ( Figure 6A ).
In comparison with PBS injection, EPC therapy in the R0ϩTx group induced an overall increase in the expression of Akt, VEGF, bFGF, and Ang-1 mRNA, and this augmentation was greatest in the R2 pigs who received EPC therapy 14 days post-MI. The administration of LY294002 significantly attenuated the increased levels of Akt, Ang-1, and bFGF induced by EPCs in both the R0 and R2 pigs, but did not cause the same degree of decrease in VEGF expression.
Western blot analysis showed the same change of Akt protein expression in all the groups ( Figure 6B ).
Because maximal Akt activity is dependent on the phosphorylation status of both Thr308 and Ser473 residues, 19 we serially measured the Akt phosphorylation with Ser473 and Thr408 antibodies. Western blotting revealed that cell therapy induced Akt phosphorylation at Thr-308 and Ser-473, and collateral vessels before cell therapy (R2) further strengthened this phosphorylation, whereas LY294002 injection markedly weakened the levels of phosphorylation. Phosphorylation of both Ser473 and Thr408 remained at low levels in both the R0ϩPBS and R2ϩPBS groups, and LY294002 injection alone further decreased the ratios of phosphorylated Ser473 and Thr408 to total Akt ( Figure 6C and 6D) . The inflammatory factors IL-1, MCP-1, and TNF␣ showed no significant difference between all the groups at 30 days post-MI (data not shown).
Immunofluorescence showed that Akt was detected in vascular ECs as well as ischemic lesions; Ang-1, bFGF, and VEGF were expressed mainly by the blood vessels and transplanted EPCs in the R2 pigs who had rich collateral vessels and received EPC therapy 14 days post-MI ( Figure  6E , arrows), but the expression levels of these mediators were significantly decreased in the R0 pigs who had poor collateral vessels and received EPC therapy at 28 days post-MI (data not shown). Collectively, these findings suggest that the initial upregulation of Akt-mediated proangiogenic cytokine expression is induced by myocardial ischemia, and EPC therapy sustains this upregulation. Figure 7A and 7E shows that rich microvessels with upregulation of Akt in the R2 groups before cell therapy caused a dose-dependent increase in the number of 4=,6-diamidino-2phenylindole (DAPI)-prelabeled EPCs in the ischemic zone, which became the most significant in the pigs that received cell therapy 14 days post-MI. LY294002 markedly decreased the number of engrafted EPCs. Transplanted EPCs in the R2ϩTx group expressed factor VIII more than in the R0ϩTx group ( Figure 7B, arrows) , whereas LY294002 injection significantly reduced this expression. All engrafted DAPI cells did not express myosin heavy chain (data not shown). As shown in Figure 7F , quantitative analysis indicated that the percentage proportions of the cells double positively stained with DAPI and factor VIII to the total positive-DAPI staining cells were the greatest in the in the R2 pigs who received EPC therapy 14 days post-MI, the secondary in the R2 pigs who received EPC therapy 1 day post-MI, and the smallest in the R0 pigs who received EPC therapy 28 days post-MI (PϽ0.05). LY294002 injection markedly decreased this percentage. A similar increase was also seen in the ratio of the cells that double-stained with DAPI and Ki-67 against the total of all of the DAPI ϩ cells (Figure 7C and 7G) . The greatest ratio between the number of double-stained Ki-67 and VIII cells/VIII ϩ cells was also seen in the R2ϩTx group that received cell therapy 14 days post-MI ( Figure 7D and 7H) . ) . B, Immunoblots showed that Akt was also upregulated at the protein level. Protein expression correlated well with mRNA expression. C, Representative Western blots of the Ser473 and Thr408 protein levels in the porcine hearts in individual groups 1 month post-Tx. Blots in both B and C represent at least 4 independent experiments. E, Immunofluorescence staining shows the local expression of Akt, VEGF, bFGF, and Ang-1 in the peri-infarct areas from the R2ϩTx groups 1 month post-Tx in the porcine hearts that received stem cell therapy 14 days post-MI. Scale barsϭ50 m. Akt, VEGF, bFGF, and Ang-1 stained red (cytoplasm stained red); the nuclei of transplanted EPCs were prelabeled with 4=,6-diamidino-2-phenylindole (DAPI) and appeared blue after staining. Some of the DAPI-prelabeled EPCs were also stained with Akt, VEGF, bFGF or Ang-1 (arrows).
The Akt Signaling-Induced Host Vascular Niche Accelerates the Propagation of Engrafted EPCs and Host ECs, and EPC Incorporation
All of the increases in cell proliferation were blocked by LY294002.
Discussion
Several new and important findings have arisen from the present study. First, infarcted porcine hearts under different time points and collateralized conditions exhibited a variety of vascular microenvironments. At 14 days post-MI, angiogenesis and the expression of Akt-mediated angiogenic cytokines predominated in the porcine hearts with a rich collateral circulation. Second, when grafted into this microenvironment, EPCs caused the greatest effects on impeding the development of heart failure, which preserved LV function and dimensions and inhibited infarct expansion. Third, the Akt inhibitor LY294002 resulted in a significant suppression of VEGF, Ang-1, and bFGF expression and a reduction in the amount of angiogenesis, host EC proliferation, and EPC proliferation. This illuminated the potential mechanisms for the observed therapeutic synergistic effect of the host vascular niche and EPC therapy on ischemic myocardial repair. Together, the findings of this study imply that the vascular niche with the greatest level of Akt-mediated angiogenic cytokine expression, angiogenesis, and collateralization before cell therapy serves as a superior microenvironment for stem cells engrafted into ischemic hearts. MI in humans and animal models results in characteristic histological and humoral changes in host niches, which consist of inflammation, angiogenesis, and soluble factor expression in the ischemic myolytic areas. 1,6,20 These Figure 7 . The cell count, distribution, cell incorporation, and proliferation of transplanted EPCs and blood vessel endothelial cells in the peri-infarct area. A, Distribution of transplanted EPCs prelabeled with 4=,6-diamidino-2-phenylindole (DAPI) (the nuclei stained blue). B, Transplanted cells expressed factor VIII at the periinfarct and infarct areas. The nuclei of transplanted cells were stained with DAPI and are shown as blue, and the cytoplasm of the blood endothelial cells was stained red with factor VIII in the R0ϩEPC transplantation (Tx), R0ϩTxϩLY294002 (LY), R2ϩTx, and R2ϩTxϩLY groups that received cell therapy at 14 days post-MI (arrows). Engrafted DAPI-prelabeled EPCs (blue) expressed factor VIII (red, yellow arrows) in the R2ϩTx group and are mainly incorporated into the vasculature and colocalize with EPCs, suggestive of differentiation. C, The results of doubleimmunostaining for DAPI and anti-Ki-67 (nuclei were stained green) in the R0ϩTx, R0ϩTxϩLY, R2ϩTx, and R2ϩTxϩLY groups that received cell therapy at 14 days post-MI (arrows). The number of cells double-stained with DAPI and Ki67 in the R2ϩTx group was greater than in the other 3 groups, and the greatest amount was seen in the R2ϩTx group. The same difference was shown in the number of double-stained cells with Ki-67 and factor VIII (D, arrows). Scale barsϭ50 m. E to H, Quantitative data of transplanted DAPI-prelabeled EPCs (E), the ratios of the cells that double-stained for DAPI and factor VIII/all the DAPI ϩ cells (F), the ratios of the cells that doublestained for DAPI and Ki-67/all the DAPI ϩ cells (G), and the ratios of the cells that double-stained for factor VIII and Ki-67/all the factor VIII ϩ cells in the peri-infarct area at 1 month post-Tx (H). PϽ0.05: *vs the groups that received EPC therapy at 1 day post-MI, †vs the group that received EPC therapy at 14 days post-MI, ‡vs R0ϩphosphate-buffered saline (PBS), § vsR0ϩLY, vs R0ϩTx, ¶vs R2ϩPBS, #vs R2ϩLY, **vs R2ϩTx (nϭ4, 3, 4, 4, 5, 4, 5, and 4 in the R0ϩPBS, R0ϩLY, R0ϩTx, R2ϩPBS, R2ϩTx, and R2ϩTxϩLY groups receiving the treatment of PBS, Tx, or LY injection at 1 day post-MI, respectively; nϭ5, 4, 5, 5, 5, 4, 5, and 4 in the R0ϩPBS, R0ϩLY, R0ϩTx, R0ϩTxϩLY, R2ϩPBS, R2ϩLY, R2ϩTx, and R2ϩTxϩLY groups at 14 days, respectively; nϭ4, 4, 4, 5, 5, and 4 in the R0ϩPBS, R0ϩTx, R0ϩLY, R2ϩPBS, R2ϩTx, and R2ϩTxϩLY groups at 28 days, respectively).
changes are believed to represent an intrinsic adaptive response of the heart to ischemia. Similar values for the vascular densities and expression levels of angiogenic factors between the individual time points occurred in the pigs without CCC (R0 pigs), which was consistent with the findings of Vandervelde et al, 6 who demonstrated that the expression of proangiogenic genes such as bFGF and VEGF changed only marginally post-MI. In the present study, we did not clarify the interaction between proangiogenic cytokines and individual cells in the ischemic niches, nor did we perform staining for activated forms of growth factor receptors in the vascular niches. These issues will be addressed in future studies. However, we indeed observed that 3 proangiogenic mediators, bFGF, Ang-1, and VEGF, were expressed mainly by the vascular ECs, and Akt protein was detected mainly by vascular EC and myocardial cells. These data suggest that these 2 cell types, particularly ECs, were key regulators for autologous angiogenesis in the ischemic niches. Furthermore, our study revealed that the R2 pig infarcted hearts with rich CCC showed a significant increase of the expression of bFGF, VEGF, and Ang-1, which was concomitant with a lower level of neutrophil attraction within 14 days post-MI; however, the inflammatory response was the strongest at the first day after MI in the infarcted hearts with R0. In parallel, Akt, a powerful modulator of angiogenesis, showed a similar pattern of progressive increases in expression in the R2 pig ischemic zone within 14 days post-MI. Moreover, the phosphorylation state of Akt at both Ser473 and Thr308 showed similar patterns of change in the total levels of cardiac Akt protein. These results imply that host endogenous angiogenesis, Akt-mediated angiogenic cytokines, and inflammation are composed of different microenvironments under a variety of settings induced by MI.
Exploration of the niches that require regeneration is indispensable for the optimization of stem cell therapy. 21 To date, there have been no preclinical or clinical studies to investigate the impact of individual stages and blood supply conditions post-MI on the efficacy and safety of cell therapy in patients or large animals with acute MI. We were the first to choose 1, 14, and 28 days post-MI as the time points that represented the acute, subacute, and chronic stages post-MI, and to use CCC (R0) or CCC (R2) as the representative models of different vascular conditions. The degree of cardiac function improvement and infarct size reduction correlated with the amount of angiogenesis and cytokine expression that was observed before cell therapy: in both the R0 and R2 groups, cell therapy was given in higher levels of angiogenesis and Akt-mediated angiogenic factor expression, and this treatment enabled a greater reduction in infarct size, improvement in cardiac function, and alleviation in LV remodeling (as shown in Table II in the online-only Data Supplement). EPC therapy at 14 days post-MI led to the greatest magnitude of these outcomes in comparison with those at other time points in R2 pigs. Other mouse studies have shown similar changes, although MI led to a transient upregulation of angiogenic cytokines and continued at this level in the EPC group. 1 In this study, there was no significant difference in LVEF and LVFS between different time points in the PBS groups, whereas cell therapy within 14 days post-MI can improve cardiac function via the upregulation of Akt pathway genes. In the Western blots of Figure 6B and 6C and the bar graph of Figure 6D , it seems that not only Akt expression but also Akt phosphorylation is increased rather than decreased regardless of any treatments involving PBS injection, EPC therapy, or LY294002 treatment after 1 and 14 days post-MI compared with after 28 days post-MI. This time difference may be of critical importance to the interpretation of the presented data. The expression of Akt, Ang-1, bFGF, and VEGF showed a similar difference, which suggests that Tx enhances the expression of Akt, Ang-1, bFGF and VEGF in a time-relative manner after MI. Moreover, these effects were found to be more significant in the R2ϩTx groups, which had high intrinsic levels of Akt and its effector genes before cell therapy. This finding implied that the synergistic effects of cell therapy with the host intrinsic Akt-mediated factors could produce the most beneficial results. In contrast, EPC therapy at 1 day post-MI did not cause as much improvement in cardiac function and infarct size in the pigs with R0 as in the pigs with R2, as the former had a higher degree of inflammation. This implied that the higher expression of inflammatory factors at 1 day post-MI did not result in the further improvement of cardiac function and infarct size, with the exception of the effect of engrafted EPCs and intrinsic angiogenic cytokines. The mechanisms of how inflammation affected the effect of EPC therapy in ischemic tissue in the present study require further investigation. The increased expression levels of Akt and cytokines alone (eg, in R0ϩTx groups) did not result in as high an enhancement of cardiac function induced by EPC therapy as the coexistence of host angiogenesis and Akt-mediated cytokines (eg, in R2ϩTx groups). Taken together, only the synergistic action of cell therapy with a superior microenvironment enriched with collateralization, proangiogenic factors, and angiogenesis could lead to these optimal effects on the repair of infarcted myocardium.
Although a direct reason for these phenomena remains unclear after this present study, there might be some regulatory factors involved in this synergistic effect. Akt (protein kinase B), a serine/threonine kinase, is activated by many growth factors, such as Ang-1, bFGF, and VEGF. [22] [23] [24] In this study, the local expression of VEGF, bFGF, and Ang-1 proteins in the peri-infarct areas was consistent with Akt expression. Thus, it can be seen that these growth factors, among others, induced by myocardial ischemia triggered Akt phosphorylation and activated Akt expression. High numbers of ECs in ischemic niches enhanced these effects. Hung et al found that the angiogenic effects of stem cells can activate the Akt pathway in a dose-dependent manner, 25 which is in agreement with our study's findings that EPC therapy further enhanced Akt expression and phosphorylation by secretion of Ang-1, bFGF, and VEGF (as shown in Figures 6A, 6E , and 3C). The findings of Babaei et al 26 demonstrated that the angiogenic effects of Ang-1 are dependent on the PI3K/Akt pathway. As the PI3K pathway is activated during angiogenesis, VEGF-or bFGF-dependent angiogenesis requires the signaling mediated by the PI3K pathway. 27 Our observations in this study also show the following: (1) the expression levels of Akt in the R2 group at 14 days post-MI correlated positively with the mRNA expression of VEGF, bFGF, and Ang-1, and the vessel density; (2) Tx in an environment with higher expression levels of Akt and Akt phosphorylation led to a substantial increase in angiogenesis and cell proliferation, and a good CCC further augmented this increase; (3) LY294002 treatment significantly suppressed Akt activity by decreasing the ratios of phosphorylated Ser473 and Thr408 to total Akt for 1 month after EPC therapy; and (4) Akt inhibitor LY294002 decreased Ang-1, bFGF, and VEGF expression and abrogated angiogenesis, which was consistent with other studies that demonstrated that inhibition of PI3K-Akt pathway blocked Ang-1-induced sprouting activity in ECs, 28 abolished bFGF-induced EC migration, 29 and reduced constitutive and hypoxia-inducible levels of VEGF. 30 This indicates that the Akt inhibitor significantly attenuates the expression of VEGF, Ang-1, and bFGF by preventing the phosphorylation of Akt in Ser473 and Thr308. Enoki et al 31 showed similar findings that the injection of LY294002 into rat hearts 1 month post-MI abrogated all of the beneficial effects of mesenchymal cell transplantation on increased neovascularization at both 3 days and 1 month after cell therapy. All of these data provide further evidence that angiogenesis and cell proliferation signals of the growth factors in ECs are mediated by both host vascular ECs and EPCs through the PI3K/Akt signal transduction pathway. Figure III in the online-only Data Supplement summarizes our current knowledge of how Akt-mediated angiogenesis and cell proliferation is regulated.
Although cotreatment with EPCs and LY294002 impaired post-MI recovery, the present study does not enable us to understand the underlying causative mechanisms: is the negative effect due to worsened vascular angiogenesis and a poor myocardial niche for EPC engraftment? Or are EPCs killed or otherwise impaired by LY294002? Additional investigations need to pretreat EPCs with LY294002 before transplantation to exclude the effect of LY294002 on EPCs. Moreover, activation of endogenous Akt is required for the full phosphorylation of Thr308 and Ser473. Phosphorylation of Ser473 by itself causes the partial activation of Akt, and only phosphorylation of both Thr308 and Ser473 acts synergistically to generate a high level of Akt activity. 19 In this study, Akt expression was different between groups, which may be correlated with the observed difference in Akt activity (phosphorylation of Ser473 and Thr308). Further work is required to clarify the mechanism of how different phosphorylation patterns of Akt at Thr308 and Ser473 in various niches result in various expression levels of Akt and phospho-Akt induced by myocardial ischemia and cell therapy. Surprisingly, we observed that LY294002 decreased Akt mRNA expression. This may be related to the regulatory feedback mechanism described in Figure III in the online-only Data Supplement, and as follows: the PI3K/Akt pathway regulating gene transcription of VEGF, bFGF, and Ang-1 in turn triggers Akt phosphorylation and activates Akt expression. Thus, LY294002 at first inhibits PI3K/Akt phosphorylation and downregulates the expression of VEGF, bFGF, and Ang-1, which in turn decreases Akt mRNA expression. LY294002 injection may lead to impairment of engrafted EPCs and host ECs, causing a reduction of the mRNA levels of Akt expressed by these cells. The precise mechanism of how LY294002 decreases Akt mRNA expression requires further investigation.
In conclusion, our findings underscore the likelihood that Akt-mediated angiogenic cytokines induced by MI not only must be considered as a part of the native physiological mechanisms that enhance angiogenesis but also act as potential synergists with EPC therapy. In this manner, the niche that is enriched with angiogenesis and proangiogenic cytokines may serve as an optimal host microenvironment for transplanted stem cells post-MI, and this area of physiology represents a potential therapeutic target for the future treatment of ischemic diseases.
